Engitix Therapeutics Alternatives & Competitors
12 companies similar to Engitix Therapeutics — Decoding the ECM space to unlock unprecedented therapies for chronic diseases
Companies similar to Engitix Therapeutics
Emulate, Inc.
Our Organ-on-a-Chip technology provides a high-fidelity window into the inner workings of...
Nordic Bioscience
Improving preclinical and clinical trial success rates with world-leading biomarkers & spe...
BioAge Labs
We are harnessing the biology of human aging to develop novel targets and therapies for me...
Paratus Sciences
Translating evolutionary insights into first-in-class medicines
Rival Readout
Competing with Engitix Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Life Biosciences
Targeting the biology of aging
Insilico Medicine
#insilicomeds, #drugdiscovery, #ai, #oncology, #RL, #DL #aging, #longevity #biologics #LLM...
Harness Therapeutics
Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases
InvivoSciences® Inc.
Discovery with Human touch
AMPLY Discovery
Turning the Dark Genome into Novel Medicines.
Apertura Gene Therapy
Bringing the Future of Gene Therapy into Focus
Gandeeva Therapeutics
Gandeeva Therapeutics uses the most advanced cryo-EM and computational tools to develop be...
InnoSIGN
Comprehensive Pathway Analysis
About Engitix Therapeutics
Engitix Therapeutics, founded in 2016 and headquartered in the United Kingdom, is at the forefront of the Biotechnology, Health Care, and Life Sciences industries. The company aims to transform therapy development for chronic diseases through its pioneering extracellular matrix (ECM)-based discovery platform. Engitix’s...
ECM Platform Development, Disease Modeling, Therapeutic Discovery, Research Collaborations
Pharmaceutical Companies, Biotech Firms, Medical Researchers, Healthcare Providers
Human Extracellular Matrix, Discovery Platform, Fibrosis Therapeutics, Solid Tumor Therapy, In Vitro Models, Drug Target Identification, Biomarker Discovery, Mechanism Of Action Study, Liver Disease Research, Regenerative Medicine, Drug Profiling, Bioartificial Liver Devices, Organ Decellularisation, Tissue Engineering, 3D Spheroids
B2B2C, Platform
Licensing, Performance Based, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Engitix Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Engitix Therapeutics on 29 Apr 2026. The 12 companies listed here were last checked between 11 Jun 2025 and 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.